Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-09-10 ROBINS CHAD M CEO and Chairman Sale −4,902 $38.37 $188K 1,673,559
2021-09-10 ROBINS CHAD M CEO and Chairman Sale −98 $39.09 $4K 1,673,461
2021-09-09 ROBINS CHAD M CEO and Chairman Sale −24,753 $38.42 $951K 1,678,461
2021-09-08 ROBINS CHAD M CEO and Chairman Sale −11,742 $38.34 $450K 1,705,218
2021-09-08 ROBINS CHAD M CEO and Chairman Sale −2,004 $39.11 $78K 1,703,214
2021-09-08 Cohen Chad M Chief Financial Officer Option exercise +5,000 $7.27 $36K 26,604
2021-09-08 Cohen Chad M Chief Financial Officer Sale −5,000 $39.01 $195K 21,604
2021-09-08 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −5,000 110,000
2021-09-07 Cohen Chad M Chief Financial Officer Option exercise +9,375 $6.55 $61K 30,979
2021-09-07 Cohen Chad M Chief Financial Officer Sale −9,375 $39.71 $372K 21,604
2021-09-07 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −9,375 65,625
2021-09-07 Taylor Stacy L SVP and General Counsel Option exercise +495 $6.55 $3K 15,531
2021-09-07 Taylor Stacy L SVP and General Counsel Sale −495 $40.00 $20K 15,036
2021-09-07 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −495 15,443
2021-08-27 GRIFFIN MICHELLE RENEE Director Option exercise +14,916 $7.80 $116K 16,420
2021-08-27 GRIFFIN MICHELLE RENEE Director Sale −14,916 $35.00 $522K 1,504
2021-08-27 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −14,916 52,084
2021-08-27 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-08-27 ROBINS HARLAN S Chief Scientific Officer Sale −961 $34.18 $33K 72,294
2021-08-27 ROBINS HARLAN S Chief Scientific Officer Sale −2,934 $34.97 $103K 69,360

Page 41 of 120 · 2,386 trades